Library

Welcome to our central library of project insights. Start by exploring our consortium and partner introduction videos. Stay tuned as we continue to add technical publications, patient stories, and project milestones.

Videos

EASYGEN - Introduction video

EASYGEN - Introduction video

EU-funded EASYGEN unites experts to advance faster, affordable, hospital-based CAR-T therapies
Watch Video
Fraunhofer-Institut für Zelltherapie und Immunologie

Fraunhofer-Institut für Zelltherapie und Immunologie

Fraunhofer IZI leads academic co-coordination and next-generation, accessible CAR-T manufacturing.
Watch Video
Fresenius Kabi

Fresenius Kabi

Fresenius Kabi brings engineering expertise to speed CAR-T cell selection, activation and gene modification
Watch Video
Helios Hospital Berlin-Buch GmbH

Helios Hospital Berlin-Buch GmbH

Helios Klinikum Berlin-Buch brings frontline clinical expertise to integrate CAR-T manufacturing into hospital
Watch Video
TQ Therapeutics GmbH

TQ Therapeutics GmbH

TQ Therapeutics develops innovative T-cell isolation technologies, enabling point-of-care CAR-T therapies.
Watch Video
we are cellix

we are cellix

Cellix brings in microfluidic technology to enable real-time T-cell quality control at the point-of-care CAR-T
Watch Video

Data insights

A caregiver’s perspective on access and waiting time

A caregiver’s perspective on access and waiting time

Caregivers face burdens from travel, uncertainty and coordination in CAR-T treatment journeys - May 7th, 2026
View the insights
CAR-T therapies: Life-saving, yet unequally accessible

CAR-T therapies: Life-saving, yet unequally accessible

Discover key insights on global CAR T access: reimbursement gaps, disparities and barriers – April 23rd, 2026
View the insights
What long CAR-T manufacturing times mean for patients

What long CAR-T manufacturing times mean for patients

See how improving CAR-T manufacturing could transform patient experiences. - April 10th, 2026
View the insights
On World Health Day, the focus is clear: Health for All.

On World Health Day, the focus is clear: Health for All.

Discover how closing the CAR-T access gap requires systems beyond science. - April 7th, 2026
View the insights
Why is CAR-T therapy access still limited for patients?

Why is CAR-T therapy access still limited for patients?

Early hospital-level insights from the EASYGEN consortium -  Febuary 19th, 2026
View the insights
Understanding who can access CAR-T therapy today

Understanding who can access CAR-T therapy today

Explore the data behind global CAR-T access, adoption, and patient barriers. Febuary 4th, 2026
View the insights

Posters

Systemic Barriers to CAR-T Access

Systemic Barriers to CAR-T Access

Systemic Barriers to CAR-T Access: Insights from a Certified German Center, first results from EASYGEN
Download the poster
EASYGEN’s potential for cost-driven innovation

EASYGEN’s potential for cost-driven innovation

CAR-T cost constraints in Europe: Budget impact, access, and EASYGEN’s potential for cost-driven innovation
Download the poster
A Process Management Perspective

A Process Management Perspective

Analysis and Optimization Potentials of Current CAR-T Cell Therapy Management: A Process Management Perspect
Download the poster

Abstracts

Coming soon...

Sign up for updates

Our newsletter keeps you connected with the EASYGEN consortium — from scientific updates to collaborative opportunities and events.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Easygen logo
About EASYGENPartnersNewsLibraryContact us
Follow us:
Linkedin logo
ImpressumPrivacy Policy
AriseHealth logoOE logo2020INC logoThe Paak logoEphicient logoToogether logoToogether logo
This project has received funding from the Innovative Health Initiative Joint Undertaking (JU) under grant agreement No 101194710. The JU receives support from the European Union’s Horizon Europe research and innovation programme and EFPIA. — Funded by the European Union, the private members, and those contributing partners of the IHI JU. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the aforementioned parties. Neither of the aforementioned parties can be held responsible for them.